Current data on lamotrigine
We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seiz...
Gespeichert in:
Veröffentlicht in: | Revista de neurologiá 2000-06, Vol.30 Suppl 1, p.S120 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | S120 |
container_title | Revista de neurologiá |
container_volume | 30 Suppl 1 |
creator | Casas-Fernández, C |
description | We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures.
We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_10904978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10904978</sourcerecordid><originalsourceid>FETCH-LOGICAL-g164t-e3c34218f1cf9a9a17ea7691371a7f247d9236d0f5d1748b94017395d6c4457a3</originalsourceid><addsrcrecordid>eNo1zr-KwkAQgPEtPNRTn0CQvEBgJjvJZEoJ3h8QbLSWMbsrERNlEwvf3sK76ut-fCMzhQwhBUCYmM--vwCQJYGxmSAIkHA5NcvqEaPvhsTpoMmtS67a3obYnJvOz81H0GvvF3-dmcPXZl_9pNvd92-13qZnLGhIva0tZVgGrIOoKLJXLgQto3LIiJ1ktnAQcodM5UkIkK3krqiJclY7M6u3e3-cWu-O99i0Gp_H_0v7AkXyNV4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Current data on lamotrigine</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Casas-Fernández, C</creator><creatorcontrib>Casas-Fernández, C</creatorcontrib><description>We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures.
We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.</description><identifier>ISSN: 0210-0010</identifier><identifier>PMID: 10904978</identifier><language>spa</language><publisher>Spain</publisher><subject>Adult ; Aged ; Anticonvulsants - adverse effects ; Child ; Child, Preschool ; Epilepsy - drug therapy ; Humans ; Infant ; Infant, Newborn ; Middle Aged ; Quality of Life ; Triazines - adverse effects</subject><ispartof>Revista de neurologiá, 2000-06, Vol.30 Suppl 1, p.S120</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10904978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casas-Fernández, C</creatorcontrib><title>Current data on lamotrigine</title><title>Revista de neurologiá</title><addtitle>Rev Neurol</addtitle><description>We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures.
We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.</description><subject>Adult</subject><subject>Aged</subject><subject>Anticonvulsants - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Epilepsy - drug therapy</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Middle Aged</subject><subject>Quality of Life</subject><subject>Triazines - adverse effects</subject><issn>0210-0010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1zr-KwkAQgPEtPNRTn0CQvEBgJjvJZEoJ3h8QbLSWMbsrERNlEwvf3sK76ut-fCMzhQwhBUCYmM--vwCQJYGxmSAIkHA5NcvqEaPvhsTpoMmtS67a3obYnJvOz81H0GvvF3-dmcPXZl_9pNvd92-13qZnLGhIva0tZVgGrIOoKLJXLgQto3LIiJ1ktnAQcodM5UkIkK3krqiJclY7M6u3e3-cWu-O99i0Gp_H_0v7AkXyNV4</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>Casas-Fernández, C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20000601</creationdate><title>Current data on lamotrigine</title><author>Casas-Fernández, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g164t-e3c34218f1cf9a9a17ea7691371a7f247d9236d0f5d1748b94017395d6c4457a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anticonvulsants - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Epilepsy - drug therapy</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Middle Aged</topic><topic>Quality of Life</topic><topic>Triazines - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casas-Fernández, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista de neurologiá</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casas-Fernández, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current data on lamotrigine</atitle><jtitle>Revista de neurologiá</jtitle><addtitle>Rev Neurol</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>30 Suppl 1</volume><spage>S120</spage><pages>S120-</pages><issn>0210-0010</issn><abstract>We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures.
We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.</abstract><cop>Spain</cop><pmid>10904978</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0210-0010 |
ispartof | Revista de neurologiá, 2000-06, Vol.30 Suppl 1, p.S120 |
issn | 0210-0010 |
language | spa |
recordid | cdi_pubmed_primary_10904978 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Adult Aged Anticonvulsants - adverse effects Child Child, Preschool Epilepsy - drug therapy Humans Infant Infant, Newborn Middle Aged Quality of Life Triazines - adverse effects |
title | Current data on lamotrigine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20data%20on%20lamotrigine&rft.jtitle=Revista%20de%20neurologi%C3%A1&rft.au=Casas-Fern%C3%A1ndez,%20C&rft.date=2000-06-01&rft.volume=30%20Suppl%201&rft.spage=S120&rft.pages=S120-&rft.issn=0210-0010&rft_id=info:doi/&rft_dat=%3Cpubmed%3E10904978%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10904978&rfr_iscdi=true |